brusatol has been researched along with Breast Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| A U, C; Bannimath, G; Bannimath, N; Beeraka, NM; Fan, R; Liu, J; Manogaran, P; Shivaprakash, P; Sinelnikov, MY; Vikram Pr, H; Zhang, J; Zhao, D | 1 |
1 other study(ies) available for brusatol and Breast Neoplasms
| Article | Year |
|---|---|
Combinatorial Implications of Nrf2 Inhibitors with FN3K Inhibitor:
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female; Humans; NF-E2-Related Factor 2; Oxaliplatin | 2023 |